BioFire Diagnostics, LLC recalls
7 notices naming BioFire Diagnostics, LLC as the recalling firm, since April 16, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
BioFire Diagnostics, LLC: Generic Name: FilmArray¿ Pneumonia Panel Generic Name: FilmArray¿ Pneumonia Panel… and 2 more
Hazard (FDA): Due to potential contaiminated of spefic lots of pneumonia and joint infection panels that could result in false positive results
FDAMedical devices
BioFire Diagnostics, LLC: BIOFIRE Respiratory Panel 2.1
Hazard (FDA): Due to increase in false negative results
FDAMedical devices
Contamination
BioFire Diagnostics, LLC: BioFire Joint Infection
Hazard (FDA): Contamination to in-vitro diagnostic test may result in false positives.
FDAMedical devices
BioFire Diagnostics, LLC: Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485
Hazard (FDA): Respiratory/sore throat panel test may result in false negative results and control failures.
FDAMedical devices
BioFire Diagnostics, LLC: BioFire Respiratory Panel 2.1
Hazard (FDA): Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.
FDAMedical devices
BioFire Diagnostics, LLC: BioFire Respiratory Panel 2.1 plus Kit
Hazard (FDA): Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.
FDAMedical devices
BioFire Diagnostics, LLC: FilmArra Pneumonia Panel plus
Hazard (FDA): Increased risk of control failures and false negative test results with multiplexed nucleic acid test.
FDAMedical devices